Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma.

Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma.

Primary effusion lymphoma (PEL) is an aggressive B-cell malignancy without effective treatment, and caused by the infection of Kaposi's sarcoma-associated herpesvirus (KSHV), predominantly in its latent form. Previously we showed that the SUMO2-interacting motif within the viral latency-associa...

Full description

Bibliographic Details
Main Authors: Ling Ding, Qing Zhu, Feng Zhou, Hongsheng Tan, Wenjia Xu, Chengling Pan, Caixia Zhu, Yuyan Wang, Hong Zhang, Wenwei Fu, Zhikang Qian, Zhenghong Yuan, Hongxi Xu, Fang Wei, Qiliang Cai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-12-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1008174

Internet

https://doi.org/10.1371/journal.ppat.1008174

Similar Items